Literature DB >> 7736427

Chromosome analysis of uterine adenomyosis. Detection of the leiomyoma-associated del(7q) in three cases.

N Pandis1, C Karaiskos, G Bardi, K Sfikas, A Tserkezoglou, S Fotiou, S Heim.   

Abstract

Adenomyosis is a uterine disease whose defining characteristic is the presence deep in the myometrium of endometrial glands and stroma. The condition is believed to arise from inordinate downward growth by contiguity from the endometrium rather than from in situ metaplasia or neoplasia. No acquired chromosome abnormalities have been associated with adenomyosis before. We analyzed short-term cultures from three cases and detected in all of them a del(7) (q21.2q31.2), a karyotypic anomaly that has hitherto been found repeatedly only in uterine leiomyomas. The cytogenetic similarity to leiomyoma suggests that the del(7q) was present in the mesenchymal or, more precisely, smooth muscle cells of the adenomyosis lesions. The very fact that clonal chromosome abnormalities were present questions whether the prevailing understanding of adenomyosis pathogenesis is adequate; the cytogenetic data would better fit a model of the disease envisioning the intramyometrial endometrial foci as having arisen through a neoplastic process.

Entities:  

Mesh:

Year:  1995        PMID: 7736427     DOI: 10.1016/0165-4608(94)00176-c

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Familial risk among patients with endometriosis.

Authors:  R M dos Reis; M F de Sá; M D de Moura; A A Nogueira; J U Ribeiro; E S Ramos; R A Ferriani
Journal:  J Assist Reprod Genet       Date:  1999-10       Impact factor: 3.412

2.  Understanding adenomyosis: a case control study.

Authors:  F Andrei Taran; Amy L Weaver; Charles C Coddington; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2009-07-30       Impact factor: 7.329

3.  Polymorphism of the IL13 gene may be associated with Uterine leiomyomas in Slovenian women.

Authors:  J Krsteski; S Jurgec; M Pakiž; I But; U Potočnik
Journal:  Balkan J Med Genet       Date:  2017-03-08       Impact factor: 0.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.